BILL · 2017–18 SESSION

HB 2556: Generic drug prices

Protecting consumers and purchasers from excessive increases in generic prescription drug prices.

Summary

States that the legislature declares that unjustified and excessive price increases of generic drugs are considered violations of the consumer protection act. Requires the prescription drug program to produce and make available to drug manufacturers a price increase notification form.

From the Bill Digest (HB 2556), written by the Legislature's nonpartisan staff. Read the full report ↗

Did not pass Did not pass · died in committee

AN ACT Relating to protecting consumers and purchasers from excessive increases in generic prescription drug prices;

No recorded floor votes. This measure never reached a floor vote.

Jan 10, 2018First reading, referred to Health Care & Wellness (Not Officially read and referred until adoption of Introduction report).

Bill numbers restart every two years, so the same number is a different bill in each session.

HB 2556 (2025–26) Washington state public bank · Did not pass · died in committee
HB 2556 (2019–20) Early learning provider regs · Enacted · Chapter 342, Laws of 2020
HB 2556 (2015–16) Academic achievement certif. · Did not pass · died in committee
HB 2556 (2013–14) Therapeutic courts · Did not pass · passed House, stalled in Senate
HB 2556 (2011–12) Thermal energy/credits · Did not pass · died in committee
HB 2556 (2009–10) Financial security/RCW 22.09 · Did not pass · passed House, stalled in Senate
HB 2556 (2007–08) Annual utility conservation · Did not pass · died in committee
HB 2556 (2005–06) Consumer-directed medical · Did not pass · died in committee